GVHD
| Characteristic . | Value . |
|---|---|
| Acute GVHD | |
| Days to onset | |
| Median | 28 |
| Range | 13-151 |
| Maximum severity, n (%) | |
| Grade 0 | 13 (28) |
| Grade I | 10 (22) |
| Grade II | 9 (20) |
| Grade III | 6 (13) |
| Grade IV | 8 (17) |
| Target organ, n (%) | |
| Skin | 28 (61) |
| Liver | 8 (17) |
| Gut | 15 (33) |
| Multiorgan | 16 (35) |
| Chronic GVHD | |
| Evaluable patients, n (%) | 26 (57) |
| Mild | 4 (15) |
| Moderate | 6 (23) |
| Severe | 2 (8) |
| Total | 12 (46) |
| Characteristic . | Value . |
|---|---|
| Acute GVHD | |
| Days to onset | |
| Median | 28 |
| Range | 13-151 |
| Maximum severity, n (%) | |
| Grade 0 | 13 (28) |
| Grade I | 10 (22) |
| Grade II | 9 (20) |
| Grade III | 6 (13) |
| Grade IV | 8 (17) |
| Target organ, n (%) | |
| Skin | 28 (61) |
| Liver | 8 (17) |
| Gut | 15 (33) |
| Multiorgan | 16 (35) |
| Chronic GVHD | |
| Evaluable patients, n (%) | 26 (57) |
| Mild | 4 (15) |
| Moderate | 6 (23) |
| Severe | 2 (8) |
| Total | 12 (46) |